BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 25820390)

  • 1. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
    Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.
    Freeman CM; Martinez CH; Todt JC; Martinez FJ; Han MK; Thompson DL; McCloskey L; Curtis JL
    Respir Res; 2015 Aug; 16(1):94. PubMed ID: 26243260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
    Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
    Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
    Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.
    Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respiration; 2015; 90(5):357-68. PubMed ID: 26447811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
    Wang RT; Li JY; Cao ZG; Li Y
    Respirology; 2013 Nov; 18(8):1244-8. PubMed ID: 23786593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
    Martinez CH; Freeman CM; Nelson JD; Murray S; Wang X; Budoff MJ; Dransfield MT; Hokanson JE; Kazerooni EA; Kinney GL; Regan EA; Wells JM; Martinez FJ; Han MK; Curtis JL;
    Respir Res; 2017 Feb; 18(1):42. PubMed ID: 28245821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
    Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients.
    Ruan W; Wu M; Shi L; Li F; Dong L; Qiu Y; Wu X; Ying K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1775-1780. PubMed ID: 28684903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
    Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
    Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progranulin is a novel biomarker for predicting an acute exacerbation of chronic obstructive pulmonary disease.
    Chen X; Liu J; Zhu M; Hu B; Bai F; Jin W; Zhou J; Chen C; Song Y; Pan J
    Clin Respir J; 2018 Oct; 12(10):2525-2533. PubMed ID: 30099848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteoglycan 4 is a diagnostic biomarker for COPD.
    Lee KY; Chuang HC; Chen TT; Liu WT; Su CL; Feng PH; Chiang LL; Bien MY; Ho SC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1999-2007. PubMed ID: 26451097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.
    Hurst JR; Donaldson GC; Perera WR; Wilkinson TM; Bilello JA; Hagan GW; Vessey RS; Wedzicha JA
    Am J Respir Crit Care Med; 2006 Oct; 174(8):867-74. PubMed ID: 16799074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.
    Bozinovski S; Hutchinson A; Thompson M; Macgregor L; Black J; Giannakis E; Karlsson AS; Silvestrini R; Smallwood D; Vlahos R; Irving LB; Anderson GP
    Am J Respir Crit Care Med; 2008 Feb; 177(3):269-78. PubMed ID: 18006888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein levels in stable COPD patients: a case-control study.
    Silva DR; Gazzana MB; Knorst MM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
    Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.